JP2014133712A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2014133712A5 JP2014133712A5 JP2013002127A JP2013002127A JP2014133712A5 JP 2014133712 A5 JP2014133712 A5 JP 2014133712A5 JP 2013002127 A JP2013002127 A JP 2013002127A JP 2013002127 A JP2013002127 A JP 2013002127A JP 2014133712 A5 JP2014133712 A5 JP 2014133712A5
- Authority
- JP
- Japan
- Prior art keywords
- amino acid
- acid sequence
- htlv
- specific
- peptide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2013002127A JP5999703B2 (ja) | 2013-01-09 | 2013-01-09 | ＨＬＡ−ＤＲ１拘束性Ｔａｘ特異的ＣＤ４＋Ｔ細胞エピトープ |
| PCT/JP2014/000053 WO2014109289A1 (ja) | 2013-01-09 | 2014-01-09 | ＨＬＡ－ＤＲ１拘束性Ｔａｘ特異的ＣＤ４＋Ｔ細胞エピトープ |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2013002127A JP5999703B2 (ja) | 2013-01-09 | 2013-01-09 | ＨＬＡ−ＤＲ１拘束性Ｔａｘ特異的ＣＤ４＋Ｔ細胞エピトープ |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2014133712A JP2014133712A (ja) | 2014-07-24 |
| JP2014133712A5 true JP2014133712A5 (https=) | 2015-11-05 |
| JP5999703B2 JP5999703B2 (ja) | 2016-09-28 |
Family
ID=51166939
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013002127A Expired - Fee Related JP5999703B2 (ja) | 2013-01-09 | 2013-01-09 | ＨＬＡ−ＤＲ１拘束性Ｔａｘ特異的ＣＤ４＋Ｔ細胞エピトープ |
Country Status (2)
| Country | Link |
|---|---|
| JP (1) | JP5999703B2 (https=) |
| WO (1) | WO2014109289A1 (https=) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2018116074A1 (en) * | 2016-12-19 | 2018-06-28 | Kabiri Mona | Chimeric peptides against htlv-1 |
| JP7411988B2 (ja) * | 2019-11-13 | 2024-01-12 | 文彦 松田 | Ｈａｍ／ｔｓｐ発症リスク判定方法 |
| WO2021167094A1 (ja) | 2020-02-20 | 2021-08-26 | 陽子 末廣 | 末梢血原料の採取／凍結融解工程における単球純化法 |
| JPWO2023163094A1 (https=) * | 2022-02-25 | 2023-08-31 | ||
| WO2025064470A1 (en) * | 2023-09-19 | 2025-03-27 | Regeneron Pharmaceuticals, Inc. | Viral peptides and uses thereof |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1986001834A1 (en) * | 1984-09-19 | 1986-03-27 | The Regents Of The University Of California | Retroviral polypeptides associated with human cellular transformation |
| US5717058A (en) * | 1993-02-23 | 1998-02-10 | Somatogen, Inc. | Peptide inhibitors of tax-dependent transcription |
| US5420244A (en) * | 1993-08-06 | 1995-05-30 | The United States Of America As Represented By The Department Of Health And Human Services | Methods and compositions for diagnosing HTLV-I associated myelopathy and adult T-cell leukemia |
| JPH09188696A (ja) * | 1996-08-01 | 1997-07-22 | Seishi Nokihara | ヒト成人白血病ワクチン用の合成ペプチド |
| CA2323632A1 (en) * | 1998-03-13 | 1999-09-16 | Epimmune Inc. | Hla-binding peptides and their uses |
| WO2004092373A1 (ja) * | 2003-04-16 | 2004-10-28 | Japan Science And Technology Agency | Ｈｔｌｖ－ｉ特異的ｃｔｌ誘導活性ペプチド |
| WO2010009465A2 (en) * | 2008-07-18 | 2010-01-21 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Htlv-ii vector and methods of use |
-
2013
- 2013-01-09 JP JP2013002127A patent/JP5999703B2/ja not_active Expired - Fee Related
-
2014
- 2014-01-09 WO PCT/JP2014/000053 patent/WO2014109289A1/ja not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Goedhals et al. | Long-lived CD8+ T cell responses following Crimean-Congo haemorrhagic fever virus infection | |
| JP6470179B2 (ja) | 結核菌（ｍ．ｔｕｂｅｒｃｕｌｏｓｉｓ）ワクチン | |
| JP2018509935A5 (https=) | ||
| EA202091335A1 (ru) | Ограниченные hla класса i t-клеточные рецепторы против мутантного ras | |
| Khan et al. | In silico predicted mycobacterial epitope elicits in vitro T-cell responses | |
| JP2014133712A5 (https=) | ||
| Wajid et al. | Prevalence of Marek's disease virus in different chicken populations in Iraq and indicative virulence based on sequence variation in the EcoRI-Q (meq) gene | |
| EA202190669A1 (ru) | Процесс получения вакцинной композиции | |
| CN116113431A (zh) | 冠状病毒疫苗 | |
| Baldwin et al. | The role of bovine γδ T cells and their WC1 co-receptor in response to bacterial pathogens and promoting vaccine efficacy: a model for cattle and humans | |
| Rowland et al. | Safety and immunogenicity of an FP9-vectored candidate tuberculosis vaccine (FP85A), alone and with candidate vaccine MVA85A in BCG-vaccinated healthy adults: a phase I clinical trial | |
| Bounds et al. | An immunoinformatics-derived DNA vaccine encoding human class II T cell epitopes of Ebola virus, Sudan virus, and Venezuelan equine encephalitis virus is immunogenic in HLA transgenic mice | |
| Hogan et al. | Cryptic MHC-E epitope from influenza elicits a potent cytolytic T cell response | |
| RU2015143164A (ru) | Пептиды kntc2 и содержащие их вакцины | |
| RU2016133598A (ru) | Композиция микобактериального антигена | |
| Leblanc et al. | VaxCelerate II: rapid development of a self-assembling vaccine for Lassa fever | |
| Swanson et al. | T-cell mediated immunity after AZD1222 vaccination: A polyfunctional spike-specific Th1 response with a diverse TCR repertoire | |
| JP2016511221A5 (https=) | ||
| Gaido et al. | Immunodominant T-cell epitopes in the VP1 capsid protein of rhinovirus species A and C | |
| JP2017538443A5 (https=) | ||
| WO2016178811A1 (en) | Modified h7 hemagluttinin glycoprotein of the influenza a/shanghai/2/2013 h7 sequence | |
| RU2013158399A (ru) | Пептиды sema5b и содержащие их вакцины | |
| Gupta et al. | Sequence analysis of Meq oncogene among Indian isolates of Marek's disease herpesvirus | |
| JP2015513314A5 (https=) | ||
| Yano et al. | A novel method for enhancement of peptide vaccination utilizing T-cell epitopes from conventional vaccines |